Netherlands· NL-248a32cba58c

Naproxen 500 mg Teva, tabletten

A naproxen product containing naproxen, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC M01AE02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about naproxenAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Naproxen is registered in 15 of 19 countries.

Countries holding a registration under ATC M01AE02 (naproxen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search naproxen products by name

Naproxen · ATC M01AE02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of naproxen costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.16 in Italy to $0.82 in Switzerland — a ×4.9 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Naproxen · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

CH Switzerland$0.82
IT Italy$0.16

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: NAPROXEN
Manufacturer: Teva Nederland B.V.
Country: Netherlands (NL)
ATC code: M01AE02
ATC class: Naproxen
Defined daily dose: 0.5 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
12571

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

495 interactions on record for naproxen.

Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check naproxen against other medicines How interaction checks work

Naproxen · interactions on record

495 records

58 severe
176 moderate
17 minor
161 info

Most severe, free to view

DicoumarolB01AA01severe
WarfarinB01AA03severe
DalteparinB01AB04severe
EnoxaparinB01AB05severe

83 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naproxen in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naproxen products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aleve, Miranax
Belgium · Aleve, Apranax
Bulgaria · Налгезин, Налгезин Форте
Cyprus · Naprorex, Priaxen
Czechia · Emoxen, Nalgesin
Germany · Aspidolo, Dolormin Für Frauen Bei Menstruationsbeschwerden Mit
Denmark · Bonyl, Naproxen Evolan
Estonia · Emox, Nalgesin Forte
Spain · Actromadol, Antalgin
Finland · Miranax, Naprometin
France · Aleve, Alevetabs
United Kingdom (Northern Ireland) · Almus Period Pain Reliever, Boots Period Pain Reliever
Greece · Anaprox, Naprosyn
Croatia · Nalgesin, Nalgesin Forte
Hungary · Aleve, Aleve Extra
Ireland · Naprosyn Ec, Naproxen Azure Pharmaceuticals
Iceland · Naproxen Viatris, Naproxen-E Viatris
Italy · Dololibre, Femmedol
Lithuania · Emox, Nalgesin Forte
Luxembourg · Aleve, Apranax
Latvia · Emox, Nalgedol
Malta · Naprorex, Naprosyn
Norway · Napren-E, Naproxen Evolan
Poland · 4flex Puregel, Aleve
Portugal · Actronadol, Ilgesin
Romania · Mobilat Pro, Naldorex
Sweden · Ipaflex, Naprocur
Slovenia · Nalgesin, Nalgesin Forte
Slovakia · Emoxen Gél, Nalgesin Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5801a3d2-93a9-40c6-a314-130c7b4160da
GET /v1/drugs/5801a3d2-93a9-40c6-a314-130c7b4160da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12571_smpc.pdf",
  "strength": null,
  "atc_label": "Naproxen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12571",
  "excipients": [
    "HYPROLOSE (E 463)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POTATO STARCH (RI)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "NAPROXEN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12571.pdf",
  "authorised_at": "1988/06/08",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "12571",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about naproxen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console